Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Experimental Cell Research|March 8, 2011
Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cellsLidia Cerquetti, Camilla Sampaoli, Donatella Amendola, et al.
Thyroid : Official Journal of the American Thyroid Association|April 8, 2004
Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacyRinaldo Guglielmi, Claudio Maurizio Pacella, Antonio Bianchini, et al.
Recenti Progressi in Medicina|August 8, 2022
[The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).]Maddalena Casale, Marina Baldini, Patrizia Del Monte, et al.
European Journal of Endocrinology|January 29, 2015
Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor responseGiuseppe Minniti, Claudia Scaringi, Maurizio Poggi, et al.
Frontiers in Endocrinology|July 5, 2022
Machine Learning-Based Texture Analysis in the Characterization of Cortisol Secreting vs. Non-Secreting Adrenocortical Incidentalomas in CT ScanRoberta Maggio, Filippo Messina, Benedetta D'Arrigo, et al.
Journal of Clinical Medicine|April 12, 2022
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with HaemoglobinopathiesMaddalena Casale, Marina Itala Baldini, Patrizia Del Monte, et al.
Annals of Hematology|March 10, 2016
Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 yearsMaurizio Poggi, Francesco Sorrentino, Pellegrina Pugliese, et al.
Endocrine|August 20, 2022
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegalySabrina Chiloiro, Denise Costa, Rosa Lauretta, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 27, 2013
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomesAntonio Bianchi, Ferdinando Valentini, Raffaella Iuorio, et al.
Drugs in Context|May 31, 2024
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiencesSabrina Chiloiro, Marialuisa Appetecchia, Antonio Bianchi, et al.
Pageof 3